Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Strategies in Early Psychosis 2

NCT07263022 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT07263022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07263022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Strategies in Early Psychosis 2
Lead sponsor
University of Minnesota
Phase
Phase 3
Overall status
Recruiting
Start date
July 17, 2026
Completion date
April 30, 2030
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder with psychotic features, cognition, major depressive disorder with psychotic features, psychosis, psychosis nos, psychotic disorder, schizoaffective disorder, schizophrenia disorder, schizophreniform disorder